The expression landscape and heterogeneity of nectin-4, HER2, and Trop-2 in urothelial carcinoma: clinicopathological correlations and implications for ADC-guided precision therapy - Quiz - MDSpire

The expression landscape and heterogeneity of nectin-4, HER2, and Trop-2 in urothelial carcinoma: clinicopathological correlations and implications for ADC-guided precision therapy

  • By

  • Shaobo Qin

  • Zhicheng Dai

  • Zhenxing Hu

  • Xiaohui Wang

  • Huiyan Zhang

  • Haotian Yang

  • Jie Liu

  • Lianghong Ma

  • July 8, 2026

  • 0 min

Share

Original Source(s)

The expression landscape and heterogeneity of nectin-4, HER2, and Trop-2 in urothelial carcinoma: clinicopathological correlations and implications for ADC-guided precision therapy

  • by Shaobo Qin, Zhicheng Dai, Zhenxing Hu, Xiaohui Wang, Huiyan Zhang, Haotian Yang, Jie Liu, Lianghong Ma

  • July 8, 2026

Related Content

Implementing exercise interventions in pediatric oncology: an expert consensus framework from the FORTEe project

Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial

Head and neck squamous cell carcinoma with femoral metastasis: a case report and systematic review of current literature